NCT00056875View on ClinicalTrials.gov

Recombinant Human Keratinocyte Growth Factor in Unrelated and Related Transplants

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 30, 2002

Study Completion Date

June 30, 2005

Conditions
Graft Versus Host Disease
Interventions
DRUG

recombinant human keratinocyte growth factor

Trial Locations (1)

48109

University of Michigan Cancer Center, Ann Arbor

All Listed Sponsors
lead

University of Michigan

OTHER

NCT00056875 - Recombinant Human Keratinocyte Growth Factor in Unrelated and Related Transplants | Biotech Hunter | Biotech Hunter